Abstract
P360 Infliximab trough levels may predict sustained response to infliximab in patients with Crohn’s disease: A single cohort study M. Bortlik1 *, D. Duricova2, K. Malickova3, A. Komarek4, N. Machkova5, E. Bouzkova6, L. Hrdlicka6, M. Lukas7. 1Iscare Lighthouse, IBD Centre, Prague, Czech Republic, 2Charles University, IBD Clinical and Research Centre, Prague, Czech Republic, 3Charles University, Institute of Clinical Biochemistry and Laboratory Diagnostics, Prague, Czech Republic, 4Faculty of Mathematics and Physics, Charles University, Department of Probability and Mathematical Statistics, Prague, Czech Republic, 5IBD Clinical And Research Center Iscare, Gastroenterology, Prague, Czech Republic, 6Charles University, IBD Clinical and Research Centre, Iscare, Prague, Czech Republic, 7Clinical Centre Isacre Lighthouse, IBD Clinical and Research Centre, Prague, Czech Republic
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
